產(chǎn)品名稱 | CD44V7抗體 |
英文名稱 | Anti-CD44v7 |
規(guī)格 | 0.1ml/100μg 0.2ml/200μg |
濃度 | 1mg/1ml |
價(jià)格 | 來電可享受優(yōu)惠 |
英文名稱 Anti-CD44v7
中文名稱 CD44V7抗體
濃 度 1mg/1ml
規(guī) 格 0.1ml/100μg 0.2ml/200μg
抗體來源 Rabbit
交叉反應(yīng) Human
產(chǎn)品類型 一抗
研究領(lǐng)域 腫瘤
蛋白分子量 predicted molecular weight: 37kDa
性 狀 Lyophilized or Liquid
免 疫 原 KLH conjugated synthetic peptide derived from humanCD44v7
亞 型 IgG
純化方法 affinity purified by Protein A
儲 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Soiumzde
產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:2000-5000 IP= IHC-P=1:50-200IHC-F=1:50-200 IF=1:50-200
（石蠟切片需做抗原修復(fù)）
not yet tested in other applications.
optimal dilutions/concentrations should be determined by theend user.
保存條件 Store at -20 °C for one year.
別 名 CD44 antigen isoform 7 precursor; LHR; BA-1; CD 44;CD44; CD44 antigen; CD44 molecule; CD44_HUMAN; CDw44; Cell surface glycoproteinCD44; chondroitin sulfate proteoglycan 8; ECMR-III; Epican; Extracellularmatrix receptor III; GP90 lymphocyte homing/adhesion receptor; hematopoieticcell E- and L-selectin ligand; Heparan sulfate proteoglycan; Hermes antigen;homing function and Indian blood group system; HSA; HUTCH-I; HUTCH1;Hyaluronate receptor; MDU2; MDU3; MIC4; MUTCH1; PGP-1; PGP1; Phagocyticglycoprotein 1; Phagocytic glycoprotein I.
